Source: Annual Congress 2009 - Airway inflammation and host defence
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
R. Cherneva, O. Georgiev, D. Petrova, N. Trifonova (Sofia, Bulgaria). α-b crystallin – a marker for inflammation in COPD patients. Eur Respir J 2009; 34: Suppl. 53, 941

Member's Comments

No comment yet.

Related content which might interest you: Targeting the IL-1β – IL-17A inflammatory axis for the treatment of viral-induced exacerbations of COPD Source: Annual Congress 2012 - Animal models of asthma and COPD and late-breaking abstracts on RCT in asthma and COPD Year: 2012 Halotherapy – A possible method to enhance airway treatment on patients with obstructive pathology Source: Annual Congress 2012 - Treatment of asthma, bronchiectasis and cough: inhaler use Year: 2012 Comorbidities associated with chronic obstructive pulmonary disease (COPD) – A clinical study Source: Annual Congress 2011 - COPD diagnosis Year: 2011 Heliox administration in patients with COPD exacerbation – Technical aspects Source: Annual Congress 2010 - Mechanical ventilation and weaning Year: 2010 Exacerbations in COPD patients – Are they related to BMI or weight loss? Source: Annual Congress 2010 - COPD: treatment and monitoring Year: 2010 Respiratory muscle function during and after a severe exacerbation of COPD – Preliminary results Source: Annual Congress 2011 - Respiratory physiotherapy in the intensive care unit and on the ward: breathing exercises and respiratory muscles Year: 2011 Chronic kidney disease (CKD) – A forgotten co-morbidity in COPD Source: Annual Congress 2012 - Inflammation in airway diseases: diagnosis and management Year: 2012 AHR to mannitol is associated with ongoing airway inflammation – a random sample population study Source: Annual Congress 2009 - Airway inflammation and asthma control Year: 2009 Imbalances in TNFα in patients with a TNFα polymorphism and a COPD phenotype Source: Annual Congress 2009 - New results in molecular pathology and functional genomics of non-neoplastic lung diseases Year: 2009 Expression of human β defensin-1 is related to progressive lung function impairment in COPD Source: Annual Congress 2009 - Pathology and immunology of COPD Year: 2009 Hedgehog-interacting protein (HHIP) polymorphisms and chronic obstructive pulmonary disease (COPD) Source: Annual Congress 2011 - Genetic and environmental risk factors for respiratory diseases Year: 2011 Differential involvement of IκB kinases α and β in asthma and COPD Source: Annual Congress 2010 - COPD and asthma: models and human studies Year: 2010 Breathlessness on bending down in COPD patients – prevalence and predictors Source: Annual Congress 2009 - Quality of life and symptoms in COPD Year: 2009 The "rapid decliner" COPD phenotype Source: Annual Congress 2010 - COPD: diagnosis Year: 2010 Chronic non-asthmatic cough – Are we nearer to define the airway pathology? Source: Annual Congress 2010 - Asthma: clinical aspects and treatment Year: 2010 pH – and serum sodium level as an important predictor of mortality in acute exacerbation of COPD Source: Annual Congress 2011 - Intensive care outcome Year: 2011 Clinical evaluation in 14 cases of diffuse alveolar hemorrhage – Relationship between initial findings and prognosis – Source: Annual Congress 2010 - Rare diffuse lung diseases Year: 2010 Tumor necrosis factor-α (TNF- α) gene polymorphysm in work-related chronic bronchitis prognosis Source: Annual Congress 2012 - COPD beyond tobacco Year: 2012 LungPoint® – A new approach to peripheral lung lesions Source: Annual Congress 2010 - Tissue is mostly the issue: diagnostic and therapeutic bronchoscopy Year: 2010 Does SpO2 correlate with SaO2 in stable COPD patients? Source: Annual Congress 2012 - Various issues in clinical physiology Year: 2012